TickerFacts.

Citius Pharmaceuticals, Inc. (CTXR): Total Liabilities

Annual figures by period end, from SEC filings.

$53.41M
As of 2025-09-30
$66.35M
As of 2026-06-30
+71.6%
3-year compound annual growth
+39.5%
5-year compound annual growth
2019-09-30: $9.59M2020-09-30: $10.10M2021-09-30: $9.65M2022-09-30: $10.57M2023-09-30: $12.18M2024-09-30: $42.55M2025-09-30: $53.41M$53.41M
2019-09-30 Total Liabilities (USD) 2025-09-30
Period endedTotal LiabilitiesChange YoYSource filing
2025-09-30$53.41M+25.5%2025-12-23, Balance as of period end
2024-09-30$42.55M+249.4%2025-12-23, Balance as of period end
2023-09-30$12.18M+15.2%2024-12-27, Balance as of period end
2022-09-30$10.57M+9.6%2023-12-29, Balance as of period end
2021-09-30$9.65M-4.5%2022-12-22, Balance as of period end
2020-09-30$10.10M+5.3%2021-12-15, Balance as of period end
2019-09-30$9.59Mn/a2020-12-16, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Citius Pharmaceuticals, Inc. (CTXR)2025-09-30$53.41M+25.5%
Silence Therapeutics plc (SLN)2025-12-31$69.14M+0.8%
Acrivon Therapeutics, Inc. (ACRV)2025-12-31$17.20M-13.1%
Zomedica Corp. (ZOMDF)2025-12-31$11.64M-0.5%
Seres Therapeutics, Inc. (MCRB)2025-12-31$93.97M-25.4%
Elite Pharmaceuticals Inc (ELTP)2026-03-31$39.41M-8.1%
Monopar Therapeutics (MNPR)2025-12-31$2.89M-45.0%
Prelude Therapeutics Inc (PRLD)2025-12-31$72.68M+65.0%
Kyntra Bio, Inc. (KYNB)2025-12-31$115.12M-71.1%

Compare CTXR, SLN, ACRV, ZOMDF side by side · Screen every company in Pharmaceutical Preparations ↗